Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database - PubMed
doi: 10.3945/ajcn.2009.28282. Epub 2009 Dec 9.
Affiliations
- PMID: 20007303
- DOI: 10.3945/ajcn.2009.28282
Free article
Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database
Heather A Ward et al. Am J Clin Nutr. 2010 Feb.
Free article
Abstract
Background: The characterization of phytoestrogen intake and cancer risk has been hindered by the absence of accurate dietary phytoestrogen values.
Objective: We examined the risk of breast, colorectal, and prostate cancers relative to phytoestrogen intake on the basis of a comprehensive database.
Design: Demographic and anthropometric characteristics, a medical history, and 7-d records of diet were collected prospectively from participants (aged 40-79 y) in the European Prospective Investigation into Cancer and Nutrition-Norfolk (EPIC-Norfolk). Five hundred nine food items were analyzed by liquid chromatography-mass spectrometry/mass spectrometry, and (13)C(3)-labeled internal standards were analyzed for isoflavones (genistein, daidzein, glycitein, biochanin A, and formononetin), lignans (secoisolariciresinol and matairesinol), and enterolignans from gut microbial metabolism in animal food sources (equol and enterolactone). From the direct analysis, values for 10,708 foods were calculated. Odds ratios (ORs) for breast (244 cases, 941 controls), colorectal (221 cases, 886 controls), and prostate (204 cases, 812 controls) cancers were calculated relative to phytoestrogen intake.
Results: Phytoestrogen intake was not associated with breast cancer among women or colorectal cancer among men. Among women, colorectal cancer risk was inversely associated with enterolactone (OR: 0.33; 95% CI: 0.14, 0.74) and total enterolignans (OR: 0.32; 95% CI: 0.13, 0.79), with a positive trend detected for secoisolariciresinol (OR: 1.60; 95% CI: 0.96, 2.69). A positive trend between enterolignan intake and prostate cancer risk (OR: 1.27; 95% CI: 0.97, 1.66) was attenuated after adjustment for dairy intake (OR: 1.19; 95% CI: 0.77, 1.82).
Conclusion: Dietary phytoestrogens may contribute to the risk of colorectal cancer among women and prostate cancer among men.
Similar articles
-
Ward HA, Kuhnle GG. Ward HA, et al. Arch Biochem Biophys. 2010 Sep 1;501(1):170-5. doi: 10.1016/j.abb.2010.05.018. Epub 2010 Jun 1. Arch Biochem Biophys. 2010. PMID: 20494649 Review.
-
Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Ward H, et al. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2891-4. doi: 10.1158/1055-9965.EPI-08-0335. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843034
-
Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA. Grace PB, et al. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):698-708. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159299
-
Zamora-Ros R, Knaze V, Luján-Barroso L, Kuhnle GG, Mulligan AA, Touillaud M, Slimani N, Romieu I, Powell N, Tumino R, Peeters PH, de Magistris MS, Ricceri F, Sonestedt E, Drake I, Hjartåker A, Skie G, Mouw T, Wark PA, Romaguera D, Bueno-de-Mesquita HB, Ros M, Molina E, Sieri S, Quirós JR, Huerta JM, Tjønneland A, Halkjær J, Masala G, Teucher B, Kaas R, Travis RC, Dilis V, Benetou V, Trichopoulou A, Amiano P, Ardanaz E, Boeing H, Förster J, Clavel-Chapelon F, Fagherazzi G, Perquier F, Johansson G, Johansson I, Cassidy A, Overvad K, González CA. Zamora-Ros R, et al. Eur J Clin Nutr. 2012 Aug;66(8):932-41. doi: 10.1038/ejcn.2012.36. Epub 2012 Apr 18. Eur J Clin Nutr. 2012. PMID: 22510793
-
Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies.
Zhang Q, Feng H, Qluwakemi B, Wang J, Yao S, Cheng G, Xu H, Qiu H, Zhu L, Yuan M. Zhang Q, et al. Int J Food Sci Nutr. 2017 Feb;68(1):28-42. doi: 10.1080/09637486.2016.1216525. Epub 2016 Aug 9. Int J Food Sci Nutr. 2017. PMID: 27687296 Review.
Cited by
-
Huang Y, Wang W, Jin J. Huang Y, et al. Front Nutr. 2024 Jul 31;11:1428911. doi: 10.3389/fnut.2024.1428911. eCollection 2024. Front Nutr. 2024. PMID: 39144286 Free PMC article.
-
Mali AV, Padhye SB, Anant S, Hegde MV, Kadam SS. Mali AV, et al. Eur J Pharmacol. 2019 Jun 5;852:107-124. doi: 10.1016/j.ejphar.2019.02.022. Epub 2019 Feb 14. Eur J Pharmacol. 2019. PMID: 30771348 Free PMC article. Review.
-
Zamora-Ros R, Forouhi NG, Sharp SJ, González CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, Clavel-Chapelon F, Fagherazzi G, Feskens EJ, Franks PW, Grioni S, Katzke V, Key TJ, Khaw KT, Kühn T, Masala G, Mattiello A, Molina-Montes E, Nilsson PM, Overvad K, Perquier F, Quirós JR, Romieu I, Sacerdote C, Scalbert A, Schulze M, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, Langenberg C, Riboli E, Wareham NJ. Zamora-Ros R, et al. Diabetes Care. 2013 Dec;36(12):3961-70. doi: 10.2337/dc13-0877. Epub 2013 Oct 15. Diabetes Care. 2013. PMID: 24130345 Free PMC article.
-
Nagata Y, Sugiyama Y, Fukuta F, Takayanagi A, Masumori N, Tsukamoto T, Akasaka H, Ohnishi H, Saitoh S, Miura T, Moriyama K, Tsuji H, Akaza H, Mori M. Nagata Y, et al. Int Urol Nephrol. 2016 Sep;48(9):1453-60. doi: 10.1007/s11255-016-1335-7. Epub 2016 Jun 4. Int Urol Nephrol. 2016. PMID: 27262851
-
Lin JH, Morikawa T, Chan AT, Kuchiba A, Shima K, Nosho K, Kirkner G, Zhang SM, Manson JE, Giovannucci E, Fuchs CS, Ogino S. Lin JH, et al. Cancer Res. 2012 Jun 15;72(12):3020-8. doi: 10.1158/0008-5472.CAN-11-2619. Epub 2012 Apr 17. Cancer Res. 2012. PMID: 22511578 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical